Laboratorio Reig Jofre, S.A. (RJF.MC)
EUR 2.97
(2.06%)
EUR 2.97
(2.06%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 85.17 Million EUR | 22.41% |
| 2022 | 69.58 Million EUR | -52.0% |
| 2021 | 144.97 Million EUR | 3.26% |
| 2020 | 140.39 Million EUR | 6.43% |
| 2019 | 131.92 Million EUR | 12.11% |
| 2018 | 117.67 Million EUR | 9.31% |
| 2017 | 107.64 Million EUR | 7.53% |
| 2016 | 100.11 Million EUR | 2.39% |
| 2015 | 97.77 Million EUR | 392.03% |
| 2014 | 19.87 Million EUR | -14.45% |
| 2013 | 23.22 Million EUR | 5.72% |
| 2012 | 21.97 Million EUR | 1.46% |
| 2011 | 21.65 Million EUR | -25.9% |
| 2010 | 29.22 Million EUR | -57.08% |
| 2009 | 68.09 Million EUR | -31.65% |
| 2008 | 99.62 Million EUR | 16.34% |
| 2007 | 85.63 Million EUR | 94.01% |
| 2006 | 44.13 Million EUR | 111.56% |
| 2005 | 20.86 Million EUR | 176.42% |
| 2004 | 7.54 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 19.64 Million EUR | 106.51% |
| 2024 Q1 | 25.41 Million EUR | 15.57% |
| 2024 Q2 | 21.98 Million EUR | -13.5% |
| 2023 Q1 | 23.34 Million EUR | 20.4% |
| 2023 Q3 | 44.2 Million EUR | 117.44% |
| 2023 FY | 85.17 Million EUR | 22.41% |
| 2023 Q2 | 20.32 Million EUR | -12.91% |
| 2023 Q4 | 21.98 Million EUR | -50.25% |
| 2022 Q4 | 19.38 Million EUR | -47.87% |
| 2022 FY | 69.58 Million EUR | -52.0% |
| 2022 Q3 | 37.18 Million EUR | 0.0% |
| 2021 Q3 | 35.44 Million EUR | 3.54% |
| 2021 Q2 | 34.23 Million EUR | -10.19% |
| 2021 Q1 | 38.11 Million EUR | -0.89% |
| 2021 FY | 144.97 Million EUR | 3.26% |
| 2021 Q4 | 37.19 Million EUR | 4.94% |
| 2020 Q3 | 32.14 Million EUR | -0.6% |
| 2020 FY | 140.39 Million EUR | 6.43% |
| 2020 Q1 | 37.46 Million EUR | -8.66% |
| 2020 Q2 | 32.33 Million EUR | -13.69% |
| 2020 Q4 | 38.45 Million EUR | 19.65% |
| 2019 Q1 | 31.81 Million EUR | -7.47% |
| 2019 FY | 131.92 Million EUR | 12.11% |
| 2019 Q4 | 41.01 Million EUR | 46.16% |
| 2019 Q3 | 28.06 Million EUR | -9.58% |
| 2019 Q2 | 31.03 Million EUR | -2.45% |
| 2018 FY | 117.67 Million EUR | 9.31% |
| 2018 Q1 | 29.89 Million EUR | -9.59% |
| 2018 Q4 | 34.37 Million EUR | 45.13% |
| 2018 Q3 | 23.68 Million EUR | -20.28% |
| 2018 Q2 | 29.71 Million EUR | -0.58% |
| 2017 FY | 107.64 Million EUR | 7.53% |
| 2017 Q4 | 33.06 Million EUR | 47.2% |
| 2017 Q3 | 22.45 Million EUR | -8.36% |
| 2017 Q2 | 24.5 Million EUR | -11.27% |
| 2017 Q1 | 27.62 Million EUR | 8.86% |
| 2016 Q3 | 22.64 Million EUR | -15.07% |
| 2016 Q4 | 25.37 Million EUR | 12.03% |
| 2016 FY | 100.11 Million EUR | 2.39% |
| 2016 Q1 | 25.41 Million EUR | 0.92% |
| 2016 Q2 | 26.66 Million EUR | 4.91% |
| 2015 FY | 97.77 Million EUR | 392.03% |
| 2015 Q2 | 24.15 Million EUR | -10.64% |
| 2015 Q3 | 21.39 Million EUR | -11.43% |
| 2015 Q4 | 25.18 Million EUR | 17.72% |
| 2015 Q1 | 27.03 Million EUR | 1745.5% |
| 2014 Q1 | 7.64 Million EUR | 67.13% |
| 2014 FY | 19.87 Million EUR | -14.45% |
| 2014 Q4 | 1.46 Million EUR | -70.47% |
| 2014 Q3 | 4.96 Million EUR | -14.5% |
| 2014 Q2 | 5.8 Million EUR | -24.13% |
| 2013 Q3 | 4.95 Million EUR | -9.23% |
| 2013 Q4 | 4.57 Million EUR | -7.74% |
| 2013 FY | 23.22 Million EUR | 5.72% |
| 2013 Q1 | 8.23 Million EUR | -12.06% |
| 2013 Q2 | 5.46 Million EUR | -33.63% |
| 2012 Q1 | 7.12 Million EUR | -2.4% |
| 2012 Q2 | 5.48 Million EUR | -23.08% |
| 2012 Q3 | 5.12 Million EUR | -6.6% |
| 2012 Q4 | 9.36 Million EUR | 82.78% |
| 2012 FY | 21.97 Million EUR | 1.46% |
| 2011 Q1 | 9.03 Million EUR | 0.0% |
| 2011 Q4 | 7.3 Million EUR | 0.0% |
| 2011 FY | 21.65 Million EUR | -25.9% |
| 2011 Q2 | 5.32 Million EUR | -41.07% |
| 2010 Q1 | 11.47 Million EUR | 0.0% |
| 2010 Q2 | 8.77 Million EUR | -23.56% |
| 2010 FY | 29.22 Million EUR | -57.08% |
| 2009 Q1 | 24.77 Million EUR | 0.0% |
| 2009 FY | 68.09 Million EUR | -31.65% |
| 2008 FY | 99.62 Million EUR | 16.34% |
| 2007 FY | 85.63 Million EUR | 94.01% |
| 2006 FY | 44.13 Million EUR | 111.56% |
| 2005 FY | 20.86 Million EUR | 176.42% |
| 2004 FY | 7.54 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Almirall, S.A. | 577.11 Million EUR | 85.241% |
| Faes Farma, S.A. | 297.11 Million EUR | 71.333% |